Changes of Cell-Free DNA Level in the Plasma of Breast Cancer Patients during Neoadjuvant Chemotherapy
Abstract
Background and Aim: Preoperative chemotherapy is increasingly given to shrink breast tumors prior to surgery. Plasma cell-free DNA (cfDNA) is elevated in cancer patients and decreases in response to effective treatments. Thus, cfDNA is considered as potential tumor marker for monitoring chemotherapy. Methods: In the present study, we investigated whether the plasma DNA concentrations in patients with breast cancer are altered during the course of CMF, CAF neoadjuvant chemotherapy. Results: In CR, PR to chemotherapy patients, the cfDNA concentration decreases from week 1 of first cycle of treatment. In contrast, it increases after 2 weeks in patients who show NC, PD, without reference to chemotherapy method. Conclusion: This study shows the possibility of using cfDNA changes as a useful biomarker with other molecular changes for personalized medicine of breast cancer.
![](https://ijcep.org/public/journals/1/article_729_cover_en_US.png)
Copyright (c) 2024 Song-Hak Kim, Ryong-Gil Ri, Hui-Myong Pak, Un-Rim Sim, Chong-Won Ri, Myong-Nam Kim, Sung-Hui Kim, Su-Hui Jang
![Creative Commons License](http://i.creativecommons.org/l/by-nc-nd/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.